Clinical Trials on Irritable Pouch Syndrome
Total 0 results
Nothing found
Sponsors and Collaborators
- Norwegian ministry of Education and Research
- Teresa Lombardi DDS private practice
- Asociación Parkinson Valencia (https://www.parkinson-valencia.com/)
- Health Future Foundation
- VA Greater Los Angeles Healthcare System
- Peter Putz
- Lene Holmvang
- Zhuhai livzon cynvenio diagnostics LTD
- Ophthotech
- Massachusetts Eye Research and Surgery Institution
- Danish Meat Research Institute
- Melissa Brooks
- Shamir Research Institute
- Acibadem Kozyatagi Hospital
- Virginia Foundation of Healthy Youth
- Community Healthcare Center dr. Adolf Drolc Maribor (HCM)
- KVT-Study Group
- University of Picardie Jules Verne
- Christian Müller, MD
- Group of Brain Doctors
- View Full List
Medical Conditions
- Pelvis Tumors
- Lung Neuroendocrine Tumor
- Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
- Developmental Language Disorder and Language Impairment
- Ann Arbor Stage IVB Hodgkin Lymphoma
- Impairment, Coordination
- Ankylosed Teeth
- Cardiovascular Outcomes
- Severe Atopic Dermatitis
- Kidney Damage
- Uncontrolled Type 2 Diabetes Mellitus
- Paralysis of Vocal Cords or Larynx
- Menopause
- Brain Arteriovenous Malformation
- Localized Unresectable Adult Primary Liver Cancer
- Coagulation Disorder Neonatal
- Gastroenteritis Rotavirus
- Cognitive Function, Social 1
- Malignant Intracranial Germ Cell Tumor
- Facial Involvement
- View Full List
Drug Interventions
- LNG-IUD (Progestin)
- Anesthesia maintenance
- 210 mg brodalumab
- 177Lu-PSMA-I&T
- Meglumine antimoniate
- Choice of intra-operative opioids were left to the discretion of anesthesiologist
- Tirapazamine
- Dolutegravir + Darunavir/ritonavir + optimized NRTI
- IGE025
- Subantimicrobial doxycycline daily
- Letrozole
- Nicotine Gum
- Risperidone Long-Acting Injection (RLAI)
- JNJ 39393406 120 mg solid X
- Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)
- Quetiapine
- Active Comparator
- Tumor-specific TCR-T cells
- Comparator: Alendronate-Teva / Duration of Treatment: 1 Month
- Vincristine
- View Full List
CROs by country
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Canada
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Pakistan
- Contract Research Organizations in South Africa
- Contract Research Organizations in South Korea
- Contract Research Organizations in Switzerland
- Contract Research Organizations in Uzbekistan
- CRO list by country